MAY 31, 2021 6:00 AM PDT

Engineering Faster, More Agile T Cell Cancer Fighters

WRITTEN BY: Tara Fernandez

Cell therapies use engineered T cells extracted from the patient’s own immune system to rally an attack on tumors. Such immunotherapies have been successful for treating “liquid cancers” such as leukemia, but the physical characteristics of solid tumors make them difficult for engineered cytotoxic T cells to infiltrate and eliminate these masses.

"The tumor is sort of like an obstacle course, and the T cell has to run the gauntlet to reach the cancer cells," said Paolo Provenzano, senior author of a research paper recently published in Nature Communications.

"These T cells get into tumors, but they just can't move around well, and they can't go where they need to go before they run out of gas and are exhausted."

In a first-of-its-kind study, Provenzano and colleagues sought to develop a method of engineering T cells using genome editing technology such that they are able to more effectively penetrate and destroy solid tumors.

"This study is our first publication where we have identified some structural and signaling elements where we can tune these T cells to make them more effective cancer fighters," explained Provenzano.

"Every 'obstacle course' within a tumor is slightly different, but there are some similarities. After engineering these immune cells, we found that they moved through the tumor almost twice as fast no matter what obstacles were in their way."

The team created subsets of specialized engineered T cells, each with unique capabilities for navigating different structural and physiological barriers to get to the malignant cells. They did this by adapting the T cells’ microtubules—building blocks of the cytoskeleton that provide cells with structure and shape—such that the cells can migrate faster and more efficiently into cancerous tissues.

The team continues to take a closer look at the mechanical properties of tumor cells using engineered nanotextured elastic platforms. In this way, they hope to create more targeted approaches to making cell-based immunotherapies more potent for solid cancers.

"Using a cell engineering approach to fight cancer is a relatively new field," commented Provenzano. "It allows for a very personalized approach with applications for a wide array of cancers. We feel we are expanding a new line of research to look at how our own bodies can fight cancer. This could have a big impact in the future."

 


Sources: Nature Communications, University of Minnesota Twin Cities.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 18, 2021
Immunology
COVID Cytokine Storm Chasers Look Inside the Lungs
MAR 18, 2021
COVID Cytokine Storm Chasers Look Inside the Lungs
Immunologists have revealed one of the underlying mechanisms behind COVID’s life-threatening cytokine storms. By s ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
APR 05, 2021
Cancer
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
APR 05, 2021
Introducing DeepTCR, the deep-learning software for T-cell receptor sequencing data
A team from the Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center is introdu ...
APR 19, 2021
Cell & Molecular Biology
Insight Into the Molecular Basis of Rheumatoid Arthritis
APR 19, 2021
Insight Into the Molecular Basis of Rheumatoid Arthritis
New research has shown how variants in an immune gene can lead to a high risk of developing the autoimmune disorder rheu ...
Loading Comments...